Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Alphabet Inc. (GOOGL): Ken Fisher’s Top Tech Stock with Unstoppable Growth

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against other best stocks to buy according to Billionaire Ken Fisher.

Ken Fisher is a prominent American investor and financial analyst, known for founding Fisher Investments in 1979. Born in San Francisco in 1950, he is the son of influential stock investor Philip A. Fisher. Fisher graduated from Humboldt State University with a degree in economics in 1972. He began his career in investment management and quickly made a name for himself through innovative approaches to investment theory.

Under Fisher’s leadership, the firm has been recognized for its investment strategies and has consistently ranked among the top investment advisers in the U.S. For several years, Fisher Investments has been included in the Financial Times’ list of top Registered Investment Advisors. Fisher is also a best-selling author, having written multiple books on investment strategies, and he is known for popularizing concepts like the Price-to-Sales ratio as a tool for stock analysis

Understanding Bull Markets and the Role of Technology in Investment Strategies

Ken Fisher talked about the markets in a September 2024 video that was posted on his firm’s YouTube channel, Fisher Investments, and mentioned that he frequently gets asked about which sectors he believes will outperform or underperform over the next 18 months. He currently sees the market in the later stages, though not at the end, of a somewhat unusual bull market shaped by the unique challenges since COVID-19 began. As this bull market nears its two-year mark in October, he observes that while major trends may not shift significantly in the immediate future, technology stocks have consistently outperformed non-tech stocks since the market began to recover from the pandemic.

Fisher noted that, when the market sees substantial movement, up or down by half a percent or more, technology stocks tend to follow that trend more intensely. Thus, if the market is expected to rise, tech stocks will likely perform well; conversely, they often lag during market downturns.

Ken Fisher Predicts Shift as Value Stocks Begin to Outperform Growth Amid Fed Rate Speculations

Ken Fisher noted that as 2024 progressed, he expected value stocks to begin outperforming growth stocks more than they had in the past. While this expectation did not materialize in the first and second quarters, he observed that the trend started to emerge in the third quarter. However, he was surprised to see that energy stocks continued to underperform compared to most value stocks.

“As 2024 progressed, and as I said in prior videos early in the year, I expected value to start doing better relative to growth than it had been before. And that didn’t really much happen in the first and second quarters. But in the third quarter of 2024, that’s largely happened, with the exception of the fact that energy, and I was completely wrong about this, energy has continued to do worse than most value.”

Additionally, Fisher said that initially when the Fed began raising rates in 2022, many thought this would negatively impact growth stocks, a narrative he consistently disagreed with. Now, the sentiment is shifting again, suggesting that central bank rate cuts will benefit value stocks while adversely affecting growth stocks. This shift is logical because value stocks are more reliant on bank financing compared to growth stocks, which have various funding sources.

As short-term interest rates decline relative to long-term rates and banks become more willing to lend, this scenario favors value stocks. Consequently, Fisher anticipates that the trend of value stocks narrowing the gap with growth stocks, seen in the third quarter, will continue into the fourth quarter and throughout much of the next year.

Our Methodology

This article explores the top ten stock holdings of Fisher Asset Management, based on 13F filings as of Q2 2024. The stocks are arranged in ascending order according to the stake of Fisher Asset Management, as of June 30, 2024.

At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A user’s hands typing a search query into a Google Search box, emphasizing the company’s search capabilities.

Alphabet Inc. (NASDAQ:GOOGL)

Total Number of Shares Owned: 48,620,515

Total Value of Shares Owned: $8,856,226,893

Number of Hedge Fund Investors: 216

Alphabet Inc. (NASDAQ:GOOGL), parent company of Google, specializes in internet-based services, advertising, and artificial intelligence innovation. Google Cloud has seen substantial growth, with Q2 2024 revenues reaching $8.5 billion—a 25% year-over-year increase—as businesses increasingly adopt cloud solutions. With robust infrastructure and advanced technology, Alphabet is well-positioned to capture a growing share of this expanding market.

Alphabet Inc. (NASDAQ:GOOGL)’s strong balance sheet and cash flow enable strategic investments in growth, research and development, and acquisitions, providing a solid foundation to navigate market fluctuations and support ongoing expansion.

In Q3 2024, Alphabet Inc. (NASDAQ:GOOGL) posted impressive results, achieving an EPS of $2.12, beating forecasts by $0.27, and recording revenue of $88.27 billion, surpassing expectations by $2.05 billion. With its Q4 earnings announcement on January 30, 2025, analysts project a steady EPS of $2.12 and revenue of $96.57 billion. Over the last 90 days, Alphabet Inc. (NASDAQ:GOOGL) has received 31 upward EPS revisions, reflecting strong investor confidence in its continued growth and leadership in the tech industry.

Diamond Hill Large Cap Strategy stated the following regarding Alphabet Inc. (NASDAQ:GOOG) in its Q2 2024 investor letter:

“Among our top individual contributors in Q2 were Amazon, Texas Instruments and Alphabet Inc. (NASDAQ:GOOG). Media and technology company Alphabet also continued delivering strong results in its search, YouTube advertising, YouTube subscription and cloud businesses. Shares rose amid an environment that continues favoring mega-cap technology companies.”

Overall, GOOGL ranks 4th on our list of best stocks to buy according to Billionaire Ken Fisher. While we acknowledge the potential of GOOGL, our conviction lies in the belief that under the radar AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than GOOGL but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…